Actively Recruiting
EsophaCap for the Detection of Early Esophageal Carcinoma
Led by Johns Hopkins University · Updated on 2025-12-16
2500
Participants Needed
2
Research Sites
675 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
CONDITIONS
Official Title
EsophaCap for the Detection of Early Esophageal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing esophagogastroduodenoscopy at Johns Hopkins Hospital from 1/2016 to 12/2025
- Age greater than 18 years
- Patients must be able to swallow a capsule
You will not qualify if you...
- Patients with extra-esophageal malignancies including head and neck and gastric cancer
- Patients who have undergone esophagectomy
- Patients who have undergone radiation to the chest
- Patients younger than 18 years
- Patients with esophageal stents
- Patients with esophageal strictures preventing passage of the capsule
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Bayview Medical Center
Baltimore, Maryland, United States, 21205
Actively Recruiting
2
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205
Actively Recruiting
Research Team
S
Stephen J Meltzer, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here